In February 2011, the inaugural meeting of the Neurohospitalist Society signified the rise of a subspecialty that is filling a need for tailored, time-sensitive treatment of patients with neurological disorders or those who are at risk for one. "We've shown having experience and expertise available 24/7 can dramatically improve these patients' care,” says UCSF neurohospitalist Andy Josephson, M.D., co-founder of the Neurohospitalist Society and a pioneer in the field.
"In the last decade, more effective neurological treatments have emerged, but speed matters," Josephson says. "When an expert is on site, anyone with a neurologic problem — whether they arrive with a primary neurologic diagnosis or another reason — can be seen quickly by a specialist."
Availability leads to experience, a second, critical advantage of a neurohospitalist program. Vanja Douglas, M.D., one of three fellowship-trained neurohospitalists on staff at UCSF Medical Center along with Josephson and Brian Scott, M.D., says, "We see so many cases, the most common and the strangest."
Add a deep understanding of inpatient systems and UCSF neurohospitalists have been able to:
Neurohospitalists at UCSF treat an unusual volume of patients with a range of conditions that include:
"Most neurologists spend about one month a year as an exclusively inpatient physician,” Josephson says. "For us, it's all we do, all year long. You can imagine how quickly the experience builds and translates to good quality care."
For more information, contact Dr. Andy Josephson or Dr. Vanja Douglas at (415) 476-1488. For the UCSF Transfer Center, call (415) 353-9166.
New MS Drug Shows Promise
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS). The study was carried out by researchers at UCSF Medical Center and other hospitals in the U.S., Canada and Europe.
UCSF Automated Pharmacy Wins Popular Science Innovation Award
UCSF Medical Center's automated pharmacy has won a 2011 Best of What's New award from Popular Science. The awards recognize 100 innovations that indicate where technology is headed in the future.